Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Neuroendocrine Carcinoma.

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase ...

Mediastinal lymphadenopathy is the medical ... Many are behind the breastbone in the pleural space, which is the tissue lining the chest and surrounding the lungs. Others surround the main veins ...

Exposure to air pollution may be linked to higher incidence of ischemic stroke, especially among non-elderly women. Exposure to air pollution may increase the risk for ischemic stroke, especially in ...

The risk of all-cause mortality was higher among patients with idiopathic pulmonary fibrosis who reported continuous use of hypnotics for insomnia. Patients with idiopathic pulmonary fibrosis (IPF) ...